|
gptkbp:instanceOf
|
company
|
|
gptkbp:acquisition
|
Actelion (2017)
Crucell_(2011)
Kenvue_(2023)
|
|
gptkbp:CEO
|
Joaquin Duato
|
|
gptkbp:drugInterdiction
|
Joaquin Duato
|
|
gptkbp:employeeCount
|
132,200 (2021)
|
|
gptkbp:founded
|
1886
|
|
gptkbp:founder
|
gptkb:Robert_Wood_Johnson
|
|
gptkbp:global_presence
|
over 60 countries
|
|
gptkbp:headquarters
|
gptkb:New_Brunswick,_New_Jersey
|
|
gptkbp:healthcare
|
gptkb:Ashley_McEvoy
Thibaut_Mongon
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Johnson & Johnson
|
|
gptkbp:industry
|
medical devices
pharmaceuticals
consumer health products
|
|
gptkbp:market
|
approximately 400 billion USD (2021)
|
|
gptkbp:partnerships
|
gptkb:World_Health_Organization
gptkb:Gavi,_the_Vaccine_Alliance
UNICEF
|
|
gptkbp:philanthropy
|
gptkb:Johnson_&_Johnson_Foundation
|
|
gptkbp:products
|
gptkb:Johnson's_Baby_Shampoo
gptkb:Listerine
gptkb:Band-Aid
gptkb:COVID-19_vaccine
gptkb:Ortho_Tri-Cyclen
Neutrogena
Immunology drugs
Tylenol
Aveeno
|
|
gptkbp:research
|
Dr. Paul Stoffels
|
|
gptkbp:revenue
|
93.77 billion USD (2021)
|
|
gptkbp:stockExchange
|
JNJ
|
|
gptkbp:subsidiary
|
gptkb:Janssen_Pharmaceuticals
DePuy Synthes
Ethicon
|
|
gptkbp:sustainability_initiatives
|
Health for Humanity 2025 Goals
Diversity_&_Inclusion_Strategy
|
|
gptkbp:trademark
|
gptkb:Clean_&_Clear
gptkb:Listerine
gptkb:Band-Aid
gptkb:Ortho_Tri-Cyclen
gptkb:Bandaid
Neutrogena
Reach
Tylenol
Motrin
Tylenol Extra Strength
Zyrtec
Aveeno
Johnson's
|